You are here

  • Home
  • Archive
  • Volume 74, Issue 5
  • Response to: ‘Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?’ by Dr Boers

Article Text

Article menu

Download PDFPDF

Electronic pages
Correspondence response
Response to: ‘Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?’ by Dr Boers
Free
  1. Camille Roubille1,
  2. Vincent Richer2,
  3. Tara Starnino3,
  4. Collette McCourt4,
  5. Alexandra McFarlane5,
  6. Patrick Fleming6,
  7. Stephanie Siu7,
  8. John Kraft8,
  9. Charles Lynde8,
  10. Janet Pope7,
  11. Wayne Gulliver9,
  12. Stephanie Keeling5,
  13. Jan Dutz4,
  14. Louis Bessette10,
  15. Robert Bissonnette11,
  16. Boulos Haraoui12
  1. 1University of Montreal Hospital Research Center (CRCHUM), Montreal, Quebec, Canada
  2. 2Department of Medicine, Dermatology Service, St-Luc Hospital, Montreal, Quebec, Canada
  3. 3Sacré-Coeur Hospital of Montreal, University of Montreal, Montreal, Quebec, Canada
  4. 4Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada
  5. 5Division of Rheumatology, University of Alberta, Edmonton, Alberta, Canada
  6. 6Division of Dermatology, University of Toronto, Toronto, Ontario, Canada
  7. 7Division of Rheumatology, Department of Medicine, Western University of Canada, St. Joseph's Health Care, London, Ontario, Canada
  8. 8Lynde Dermatology, Markham, Ontario, Canada
  9. 9Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada
  10. 10Department of Medicine, Centre de Recherche du CHU de Québec, Laval University, Quebec City, Quebec, Canada
  11. 11Innovaderm Research, Montreal, Quebec, Canada
  12. 12Department of Medicine, Rheumatic Disease Unit, Centre Hospitalier de l'Université de Montréal (CHUM) and Institut de Rhumatologie de Montréal, Montreal, Quebec, Canada
  1. Correspondence to Dr Boulos Haraoui, Institut de Rhumatologie de Montreal, 1551 Ontario Street East, Montreal, Quebec, Canada H2L 1S6; boulos.haraoui{at}ssss.gouv.qc.ca

https://doi.org/10.1136/annrheumdis-2015-207419

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Dr Boers for the interesting comments1 on our paper2. First, the decision to exclude studies reporting less than 400 patients was made after noticing that most of these studies had less than 1 year of follow-up or had large drop-outs with few remaining patients at or beyond 1 year. We also reviewed the abstract by Tarp et al.3 Among a total of 4831 subjects, 1944 were specifically analysed for …

    View Full Text

    Linked Articles